Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03983681 · ClinicalTrials.gov registry record · NA
Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS
A NA study of Multiple Sclerosis, sponsored by Kessler Foundation.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 2
- Study locations
NCT03983681: Active NA study of Multiple Sclerosis, sponsored by Kessler Foundation.
NCT03983681 is a NA study of Multiple Sclerosis that is active but no longer recruiting, run by Kessler Foundation. The registered enrollment target is 120 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03983681, a NA study of Multiple Sclerosis, is active but no longer recruiting, sponsored by Kessler Foundation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research study is to investigate the effectiveness of a memory enhancement technique in persons with Multiple Sclerosis.
Primary Outcome
Perceived Deficits Questionnaire
Conditions Studied
Interventions
- BEHAVIORAL Strategy-Based Training to Enhance Memory (STEM)
- BEHAVIORAL Placebo control exercises
Study Locations (2)
New Jersey
- Kessler Foundation - East Hanover
- Kessler Rehabilitation Center - Marlton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2019-09-26 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
What the registry record for NCT03983681 still lists
NCT03983681 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Strategy-Based Training to Enhance Memory (STEM) is the first listed.
NCT03983681 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT03983681 about?
NCT03983681 is a clinical study titled "Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS". The purpose of this research study is to investigate the effectiveness of a memory enhancement technique in persons with Multiple Sclerosis.
What is the current status of trial NCT03983681?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2019-09-26. Estimated completion is 2025-09-30.
What conditions does trial NCT03983681 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
What interventions are being tested in trial NCT03983681?
The interventions under investigation include: Strategy-Based Training to Enhance Memory (STEM) (BEHAVIORAL), Placebo control exercises (BEHAVIORAL).
Who is sponsoring clinical trial NCT03983681?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03983681 being conducted?
This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03983681's enrollment target sits among peer trials
120 111th of 315 higher than 197 of 315 other Multiple Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Intermittent Hypoxia in Persons With Multiple Sclerosis
RECRUITING · NA
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Central Vein Sign in Multiple Sclerosis Extension Study
RECRUITING · NA
-
Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI